A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy
Clinical trial NCT04866108 · UNKNOWN
Trial details
- NCT number
- NCT04866108
- Sponsor
- Beijing Friendship Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-08
- Primary completion
- 2024-06-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.